Table 1: administration of adjuvant chemotherapy in relation to the use of MammaPrint

  NChemotherapy (%)p-value
Group ANo Mammaprint12261 (47%) 
 Mammaprint194 (21%)0.019
 Low riks/High risk15/3  
 ACT in line with GS89%  
Broup BNo Mammaprint1229507 (41%) 
 MammaPrint22675 (33%)0.016
 Low/ risk/High risk125/74  
 ACT in line with GS86%  
Group CNo MammaPrint397209 (53%) 
 MammaPrint6226 (42%)0.117
 Low risk/High risk34/23  
 ACT in line with GS84%